LONGBIO-B

01779

----

Current ValuationThe current P/E ratio is -17.86, above the reasonable range, cheaper than 0% of the time in the past 1 years, and the industry ranks 59/78, the industry Median -4.74.

-17.86xP/E

Stock priceHK$58.25Earnings per shareHK$-3.26

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0165330495660

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
09926HKAKESO	-71.08x	75.71%	HK$79.15B
09688HKZAI LAB	-14.47x	378.75%	HK$21.36B
01877HKJUNSHI BIO	-36.20x	85.34%	HK$16.76B
09606HKDUALITYBIO-B	-8.14x	85.62%	HK$13.48B
07666HKMETIS TECHBIO-P	-32.72x	96.71%	HK$13.32B
02627HKAB&B BIO-TECH-B	-46.87x	--	HK$11.54B
06855HKASCENTAGE	-6.68x	18.76%	HK$11.30B
02595HKGENFLEET-B	-7.09x	66.07%	HK$10.75B
01952HKEVEREST MED	-166.16x	324.72%	HK$10.31B
02493HKMABWELL-B	-7.84x	--	HK$8.48B
02616HKCSTONE PHARMA-B	-16.29x	1.77%	HK$7.86B
06938HKRIBOLIFE-B	-39.99x	29.56%	HK$7.81B
09887HKLEADS BIOLABS-B	-22.62x	3.57%	HK$6.95B
02171HKCARSGEN-B	-64.64x	51.05%	HK$6.64B
09966HKALPHAMAB-B	-32.28x	--	HK$6.54B
01672HKASCLETIS-B	-8.61x	78.53%	HK$5.87B
02256HKABBISKO-B	-9.26x	800.99%	HK$4.97B
06872HKTENNOR THERAP-B	-30.47x	--	HK$4.89B
00775HKCKLIFE SCIENCES	-73.53x	--	HK$4.76B
02335HKMICOT PHARMA-B	-11.18x	37.52%	HK$4.69B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.